Approval · Notice of Compliance 3663 · 1997
LEUSTATIN: Notice of Compliance 3663
Issued October 6, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3663
- Date
- October 6, 1997
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic/chemotherapeutic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEUSTATIN | 02022117 | Cancelled Post Market |
Medicinal ingredients
- CLADRIBINE 1 MG per ML